Cell-free DNA as a complementary marker of therapeutic futility in adenoid cystic carcinoma

Our findings suggest that ctDNA may serve as an additional tool for therapeutic guidance in ACC patients.

Authors

Institutions

Publication Details

Journal
Oral Oncology
Published
2025-09-17
DOI
https://doi.org/10.1016/j.oraloncology.2025.107688
Citations
1
Primary Topic
Cancer Genomics and Diagnostics
Type
article
Field-Weighted Citation Impact
0.94
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cell-free DNA as a complementary marker of therapeutic futility in adenoid cystic carcinoma

Hazel Stuart, Joanna Blocka, Klothilda Lim, Glenn J. Hanna et al.
1 citations
Oral Oncology
Cancer Genomics and Diagnostics
0.94
article

Cell-free DNA as a complementary marker of therapeutic futility in adenoid cystic carcinoma

Hazel Stuart, Joanna Blocka, Klothilda Lim, Glenn J. Hanna, Nathaniel G. Tadros, Birgit Knoechel, Jens G. Lohr, Julia Frede, Caroline R.M. Wiggers
article en
1 citations

Abstract

Our findings suggest that ctDNA may serve as an additional tool for therapeutic guidance in ACC patients.

Oral OncologyVol. 169
Harvard University (US), Heidelberg University (DE), Huntsman Cancer Institute (US), University Hospital Heidelberg (DE), Dana-Farber Cancer Institute (US)
Openalex Percentile: Top 20%
Cancer Genomics and Diagnostics
0.94
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.